BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 25276147)

  • 1. NQO1 C609T polymorphism and colorectal cancer susceptibility: a meta-analysis.
    Zheng B; Wang Z; Chai R
    Arch Med Sci; 2014 Aug; 10(4):651-60. PubMed ID: 25276147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between NQO1 C609T polymorphism and colorectal cancer risk.
    Wang Y; Zhang G; Luo Y
    Tumour Biol; 2013 Dec; 34(6):4027-32. PubMed ID: 23893397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "NQO1 Gene C609T Polymorphism (dbSNP: rs1800566) and Digestive Tract Cancer Risk: A Meta-Analysis.".
    Yadav U; Kumar P; Rai V
    Nutr Cancer; 2018; 70(4):557-568. PubMed ID: 29652514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between NQO1 C609T polymorphism and bladder cancer susceptibility: a systemic review and meta-analysis.
    Gong M; Yi Q; Wang W
    Tumour Biol; 2013 Oct; 34(5):2551-6. PubMed ID: 23749485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T gene polymorphism association with digestive tract cancer: a meta-analysis.
    Zhu CL; Huang Q; Liu CH; Lin XS; Xie F; Shao F
    Asian Pac J Cancer Prev; 2013; 14(4):2349-54. PubMed ID: 23725139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NAD(P)H quinone oxidoreductase 1 (NQO1) genetic C609T polymorphism is associated with the risk of digestive tract cancer: a meta-analysis based on 21 case-control studies.
    Yang FY; Guan QK; Cui YH; Zhao ZQ; Rao W; Xi Z
    Eur J Cancer Prev; 2012 Sep; 21(5):432-41. PubMed ID: 22387672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of NQO1 C609T polymorphism on prostate cancer risk: a meta-analysis.
    Zhang Q; Zheng M; Qi XL; Liu F; Mao ZJ; Zhang DH
    Onco Targets Ther; 2014; 7():907-14. PubMed ID: 24940075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between NQO1 C609T polymorphism and acute lymphoblastic leukemia risk: evidence from an updated meta-analysis based on 17 case-control studies.
    Li C; Zhou Y
    J Cancer Res Clin Oncol; 2014 Jun; 140(6):873-81. PubMed ID: 24488035
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Huang J; Lin H; Wu X; Jin W; Zhang Z
    Oncotarget; 2017 Nov; 8(60):102301-102309. PubMed ID: 29254245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between NQO1 C609T polymorphism and prostate cancer risk.
    Sun Z; Cui Y; Pei J; Fan Z
    Tumour Biol; 2014 Aug; 35(8):7993-8. PubMed ID: 24838947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A meta-analysis of the association between NQO1 C609T variation and acute myeloid leukemia risk.
    Li C; Liu Y; Wei S; Zhou Y
    Pediatr Blood Cancer; 2014 May; 61(5):771-7. PubMed ID: 24474393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of the NQO1 C609T polymorphism with Alzheimer's disease in Chinese populations: a meta-analysis.
    Luo J; Li S; Qin X; Peng Q; Liu Y; Yang S; Qin X; Xiong Y; Zeng Z
    Int J Neurosci; 2016; 126(3):199-204. PubMed ID: 25562627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations of NQO1 C609T and NQO1 C465T polymorphisms with acute leukemia risk: a PRISMA-compliant meta-analysis.
    He H; Zhai X; Liu X; Zheng J; Zhai Y; Gao F; Chen Y; Lu J
    Onco Targets Ther; 2017; 10():1793-1801. PubMed ID: 28367062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The NQO1 polymorphism C609T (Pro187Ser) and cancer susceptibility: a comprehensive meta-analysis.
    Lajin B; Alachkar A
    Br J Cancer; 2013 Sep; 109(5):1325-37. PubMed ID: 23860519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of NQO1 rs1800566 polymorphism and the risk of colorectal cancer: a meta-analysis.
    Ding R; Lin S; Chen D
    Int J Colorectal Dis; 2012 Jul; 27(7):885-92. PubMed ID: 22215148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism and lung cancer risk: a meta-analysis.
    Lou Y; Li R; Xiong L; Gu A; Shi C; Chu T; Zhang X; Gu P; Zhong H; Wen S; Han B
    Tumour Biol; 2013 Dec; 34(6):3967-79. PubMed ID: 23852860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association between IL-1 family gene polymorphisms and colorectal cancer: A meta-analysis.
    Liu L; Zhai Z; Wang D; Ding Y; Chen X; Wang Q; Shu Z; Wu M; Chen L; He X; Fan D; Pan F; Xing M
    Gene; 2021 Feb; 769():145187. PubMed ID: 32998046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The NQO1 C609T polymorphism and hepatocellular carcinoma risk.
    Fan Y; Hu D; Feng B; Wang W
    Tumour Biol; 2014 Aug; 35(8):7343-50. PubMed ID: 24532470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The NQO1 C609T polymorphism and risk of lung cancer: a meta-analysis.
    Liu Y; Zhang D
    Asian Pac J Cancer Prev; 2011; 12(11):3091-5. PubMed ID: 22393995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MTHFR C677T polymorphism contributes to colorectal cancer susceptibility: evidence from 61 case-control studies.
    Sheng X; Zhang Y; Zhao E; Lu S; Zheng X; Ge H; Lu W
    Mol Biol Rep; 2012 Oct; 39(10):9669-79. PubMed ID: 22729883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.